CATS News and Press, Catasys From 05/12/20

April net enrollment momentum continuing in May Catasys, Inc. (NASDAQ: CATS) (“Catasys” or the “Company”), a leading AI-powered and telehealth-enabled, virtualized outpatient healthcare treatment company, today announced the expansion of its OnTrak-A s...

Behaviour is the mirror in which everyone shows their image. - Johann Wolfgang Von Goethe The popular theory goes that the defensive sectors only come to the party when the going gets tough and the economic cycle turns; well, there’s no arguing with that in Q1-20, where one saw the ...

Catasys, Inc. (CATS) Q1 2020 Earnings Conference Call May 7, 2020 4:30 PM ET Company Participants Brandon LaVerne – Chief Financial Officer Curtis Medeiros – President and Chief Operating Officer Terren Peizer – Chairman and Chief Executive Officer Confere...

Image source: The Motley Fool. CATASYS INC   (NASDAQ: CATS) Q1 2020 Earnings Call May 07, 2020 , 4:30 p.m. ET Operator Continue reading

Gainers: Protagonist Therapeutics (NASDAQ: PTGX ) +74% . More news on: Protagonist Therapeutics, Inc., Everspin Technologies, Inc., American Axle & Manufacturing Holdings, Inc., Stocks on the move, , Read more ...

The following slide deck was published by Catasys, Inc. in conjunction with their 2020 Q1 earnings Read more ...

Catasys (NASDAQ: CATS ): Q1 Non-GAAP EPS of -$0.32; GAAP EPS of -$0.45 misses by $0.02 . Revenue of $12.34M (+81.5% Y/Y) beats by $0.27M . Press Release More news on: Catasys, Inc., Earnings news and commentary, Healthcare stocks news,

Record Quarterly Revenue of $12.3 Million in Q1 2020, up 81% Year over Year and up 5% from Q4 2019 Effective Outreach Pool Increased to 145,000 in Q1 2020, up 202% Year over Year and up 34% from 108,000 at Q4 2019 Record Quarterly Net Enrollment increase of 1,604 in Q1 2020, ...

Catasys, Inc. (NASDAQ: CATS) (“Catasys” or the “Company”), a leading AI and technology-enabled healthcare company, today announced that the Company will be releasing financial results for its first quarter ended March 31, 2020, after the closing of the stock mark...

Allscripts Healthcare Solutions (NASDAQ: MDRX ) initiated with Outperform rating and $8 (21% upside) price target at RBC. More news on: Allscripts Healthcare Solutions, Inc., Aprea Therapeutics, Inc., Avita Medical Limited, Healthcare stocks news, Stocks on the move, , Read more ...